Tag: TFEU
The Court of Justice’s Judgment in Allianz Hungria is Wrong and...
Patrick Harrison, May 14, 2013
The Court of Justice's March 2013 judgment in Allianz Hungária may constitute the single most significant development in EU competition law...
The Norwegian Government Proposes Amendments to the Competition Act: Welcome Changes...
Eirik Osterud, Harald Selte, Beret Sundet, Apr 29, 2013
On March 15, 2013, the Norwegian Government submitted its Proposition (Prop. 75 L (2012-2013)) for amendments...
Information Exchange in the Framework of a Merger
Edurne Navarro Varona, Apr 29, 2013
Information exchange in the framework of a merger constitutes an important issue where the demands of the course of...
Hungarian Competition Law & Policy: The Watermelon Omen
Pal Szilagyi, Oct 30, 2012
Looking at recent developments in Hungarian competition law and policy first gives us the impression that nothing exciting is happening....
Innovation is King. Or is it?
David Cardwell, Paul Lugard, Oct 05, 2012
Nowadays, it is undisputed that innovation is a key driver of consumer welfare. As a result, unwarranted restraints...
Are Rights Finally Becoming Fundamental?
Patrick Harrison, Kristina Nordlander, Feb 22, 2012
In the landmark 2005 Article 102 TFEU case regarding Losec, AstraZeneca was fined EUR 60 million for conduct...
Innovation is King. Or is it?
David Cardwell, Paul Lugard, Oct 05, 2012
Nowadays, it is undisputed that innovation is a key driver of consumer welfare. As a result, unwarranted restraints...
Hungarian Competition Law & Policy: The Watermelon Omen
Pal Szilagyi, Oct 30, 2012
Looking at recent developments in Hungarian competition law and policy first gives us the impression that nothing exciting is happening....
Abuse of Regulatory Procedures in the Pharmaceutical Sector Developments Since the...
Patrick Harrison, Kristina Nordlander, Jul 27, 2012
In June 2005, the European Commission issued a decision finding that AstraZeneca had breached Article 102 TFEUby engaging...
From Astra-Zeneca to Pfizer: When Protection of Originators Patents Ceases to...
Stefano Grassani, Jul 27, 2012
On Jan. 11, 2012, the Italian Antitrust Authority ("IAA") found Pfizer Inc. and its Swedish and Italian subsidiaries guilty of...
